A measured succinct reflection on MagLev and older ventricular assist devices, on the occasion of a relevant 'expert opinion' paper on the topic.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
October 27, 2017
October 12, 2017
The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to 14 days for a variety of indications including post MI, heart transplant, open heart surgery, or right heart failure after LVAD implant.
September 29, 2017
Patient Care A Brazilian woman ran a road race in Rio de Janiero, powered by the transplanted heart of a German Olympian that she had received only a year earlier.
September 19, 2017
The authors queried the UNOS heart transplantation database to determine if LVAD device-related complications (DRCs) were associated with worse postoperative graft survival. The 5 categories of DRCs were as follows: device thrombosis, infection, device malfunction, life-threatening arrhythmias, and others.
September 14, 2017
This study details the short- and long-term outcomes for more than 3,000 patients who underwent septal myectomy for hypertrophic cardiomyopathy at the Mayo Clinic in Rochester, United States, from 1993 to 2016.
July 7, 2017
Patient Care A boy’s growth had fallen well behind that of his twin brother, leading doctors in Abu Dhabi, UAE, to discover and surgically treat a congenital heart condition.
May 11, 2017
I was moved by this editorial on global health matters in a daily British newspaper by an academic medical colleague, written in response to anticipated changes in the leadership of the World Health Organisation. It is perhaps time for us surgeons to augment our administrative participation in global healthcare.
March 29, 2017
The esteemed authors are to be commended on the detailed but readable desciption of their technique under the heading 'Indication and Surgical Technique of Extracorporeal Membrane Oxygenation and CentriMag Device' (page 753)
March 28, 2017
The authors report here on the results of the Italian CHEETAH study, a randomized, double-blind, placebo-controlled trial examining whether adding the unique inotrope levosimendan—in low doses—improves 30-day mortality after cardiac surgery in patients with perioperative LV dysfunction.
Changes in End-Organ Function in Patients With Prolonged Continuous-Flow Left Ventricular Assist Device Support
March 5, 2017
Changes in end organ function were assessed in 59 pts having a continuous flow LVAD in place for more than 3 years. Renal and hepatic function improved initially, but renal function deteriorated to preoperative levels during the follow-up period.